Abstract
Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s):
Issue: Mar/Apr 2025 - Volume 29, Number 2
Page(s): 121
Download in electronic PDF format for $75
Abstract
In the article “Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration,” [Reference: Int J Pharm Compd. 2021; 25 (1): 52-61.] Table 1, row 33 states that the challenge drug was “Total Parenteral Nutrition, Hospira (Lot 87-308-DK).” This challenge drug description should be corrected to “TPN Electrolytes, Hospira (Lot 87-308-DK).